RZLT
Rezolute, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +16.7% ·
share flow +28.0% ·
net new positions +14.3%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 64 | +3 | 50.24M | $261.09M | +9 | −6 |
| Q1 2026 | 63 | +7 | 53.20M | $162.23M | +14 | −7 |
| Q4 2025 | 56 | +1 | 61.70M | $145.62M | +3 | −2 |
| Q3 2025 | 14 | +1 | 31.48M | $295.95M | +2 | −1 |
| Q2 2025 | 10 | 0 | 26.66M | $118.90M | +2 | −2 |
| Q1 2025 | 7 | -1 | 3.87M | $11.23M | — | −1 |
| Q4 2024 | 8 | 0 | 4.74M | $23.24M | — | — |
| Q3 2024 | 7 | +1 | 2.88M | $13.99M | +1 | — |
| Q2 2024 | 6 | — | 2.25M | $9.69M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Marshall Wace ✦ | 1.13M | +7.8% | $5.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Marshall Wace ✦ | 1.13M | +7.8% | $5.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 491.60K | +39.0% | $2.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 491.60K | +39.0% | $2.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 376.25K | +11.5% | $1.82M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 376.25K | +11.5% | $1.82M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Adage Capital Partners ✦ | 315.85K | 0.0% | $1.53M | 0.0% | Held | 2 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 278.30K | +54.2% | $1.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 221.45K | +1154.6% | $1.07M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 71.58K | New | $347,168 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Two Sigma Investments | $347,168 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 81.00K shares, $247 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.